Vicarius Pharma Overview

  • Founded
  • 2016
  • Status
  • Out of Business
  • Employees
  • 3
  • Latest Deal Type
  • Liquidation

Vicarius Pharma General Information


Developer and executor of European go-to-market strategies designed for specialty, rare or orphan and hospital products. The company's services provide advice to innovator companies on their European presubmission and pre-approval strategies and manage the go-to-market process with flexible, tailored partnership models, enabling U.S.-based pharmaceutical companies to execute and commercialize their product in Europe.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Consulting Services (B2B)
Other Industries
Media and Information Services (B2B)
Other Healthcare Services
Primary Office
  • Bodenstrasse 23
  • 6403 Kuessnacht
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vicarius Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 21-Jul-2020 000.00 Completed Bankruptcy: Liquidation
1. Early Stage VC (Series A) 14-Aug-2017 000.00 000.00 000.00 Completed Generating Revenue
To view Vicarius Pharma’s complete valuation and funding history, request access »

Vicarius Pharma Executive Team (7)

Name Title Board Seat Contact Info
Eric Hoffman Ph.D Head, Business Development
You’re viewing 1 of 7 executive team members. Get the full list »

Vicarius Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial